Home
About
Overview
Sharing Data
ORCID
Help
History (14)
MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing.
Randomized trial of adjunctive topiramate therapy in infants with refractory partial seizures.
Characterizing and validating 12-month reliable cognitive change in Early-Onset Alzheimer's Disease for use in clinical trials.
New imaging modalities to distinguish rare uterine mesenchymal cancers from benign uterine lesions.
Determinants of neurodegenerative decline in the aphasic variant of Alzheimer's disease
See All 14 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Determinants of neurodegenerative decline in the aphasic variant of Alzheimer's disease
Overview
sponsor award id
R01AG056258
Biography
contributor
Principal Investigator
Time
start date
2012-03-15
end date
2024-02-29